StockNews.AI
CRON
StockNews.AI
2 days

Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders

1. Cronos Group's recent Annual Meeting saw 71.87% shareholder participation. 2. All director nominees received over 92.3% of votes in their favor. 3. 94.13% of votes approved the executive compensation resolution. 4. Davidson & Company LLP was appointed as the independent auditor. 5. Cronos is focused on innovation in cannabis research and product development.

4 mins saved
Full Article

FAQ

Why Bullish?

Strong shareholder support and board stability can positively influence investor confidence.

How important is it?

High support for directors indicates a stable leadership that may drive future growth.

Why Short Term?

The immediate results of this meeting can affect shareholder sentiment and stock price quickly.

Related Companies

GTBIFAPHA
June 23, 2025 17:30 ET  | Source: Cronos Group Inc. TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Friday, June 20, 2025 (the “Meeting”), shareholders holding a total of 276,989,452 common shares of the Company voted in person or by proxy, representing 71.87% of the total number of common shares of the Company outstanding. Each of the directors listed as a nominee in the Company’s definitive proxy statement dated April 25, 2025 was elected as a director of the Company, with each director receiving in excess of 92.3% of the votes cast in favor of his or her election. The detailed results of the vote for the election of directors are as follows: Name of DirectorNumber of Shares Voted ForPercentage of Shares Voted ForNumber of Shares Withheld from VotingPercentage of Shares Withheld from VotingMichael Gorenstein206,219,87592.38%17,012,4437.62%Jason Adler215,665,94696.61%7,566,3723.39%Murray Garnick215,548,31296.56%7,684,0063.44%Kamran Khan216,349,69496.92%6,882,6243.08%Dominik Meier216,404,34796.94%6,827,9713.06%Elizabeth Seegar211,177,23294.60%12,055,0865.40%James Rudyk215,956,20396.74%7,276,1153.26% Shareholders also approved an advisory (non-binding) resolution on the compensation of the Company’s named executive officers, with 94.13% of votes cast in favor of such resolution, and approved the appointment of Davidson & Company LLP as the Company’s independent auditor for fiscal year 2025 and authorized the Board of Directors of the Company to fix the independent auditor's remuneration. For complete results on all matters voted on at the Meeting, please see the Report of Voting Results filed on the Company’s SEDAR+ profile at www.sedarplus.com and the Company’s Form 8-K filed on EDGAR at www.sec.gov/edgar. About Cronos Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS® and Lord Jones®. For more information about Cronos and its brands, please visit: thecronosgroup.com. For further information, please contact:Harrison AaronInvestor RelationsTel: (416) 504-0004investor.relations@thecronosgroup.com

Related News